Yousuke Furuta

7.8k total citations · 2 hit papers
57 papers, 5.1k citations indexed

About

Yousuke Furuta is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yousuke Furuta has authored 57 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 25 papers in Epidemiology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yousuke Furuta's work include Viral Infections and Vectors (30 papers), Viral Infections and Outbreaks Research (29 papers) and Influenza Virus Research Studies (17 papers). Yousuke Furuta is often cited by papers focused on Viral Infections and Vectors (30 papers), Viral Infections and Outbreaks Research (29 papers) and Influenza Virus Research Studies (17 papers). Yousuke Furuta collaborates with scholars based in Japan, United States and China. Yousuke Furuta's co-authors include Takashi Komeno, Brian B. Gowen, Donald F. Smee, Kazumi Takahashi, Takaaki Nakamura, Kimíyasu Shiraki, Dale L. Barnard, John D. Morrey, Justin G. Julander and Nobuhiko Nomura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Yousuke Furuta

57 papers receiving 5.0k citations

Hit Papers

Favipiravir (T-705), a novel viral RNA polymerase inhibitor 2013 2026 2017 2021 2013 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Favipiravir (T-705), a novel viral RNA polymerase inhibitor
    2013 798 citations Yousuke Furuta, Brian B. Gowen et al. Antiviral Research profile →
  2. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
    2017 790 citations Yousuke Furuta, Takashi Komeno et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yousuke Furuta Japan 33 3.5k 2.1k 750 689 521 57 5.1k
Brian B. Gowen United States 34 2.8k 0.8× 1.1k 0.6× 669 0.9× 804 1.2× 657 1.3× 93 4.4k
Friederike Feldmann United States 47 6.1k 1.8× 2.8k 1.3× 970 1.3× 579 0.8× 908 1.7× 146 8.0k
Dana Scott United States 43 5.4k 1.6× 1.9k 0.9× 711 0.9× 886 1.3× 581 1.1× 107 6.7k
Dale L. Barnard United States 34 2.4k 0.7× 1.6k 0.8× 1.0k 1.4× 332 0.5× 764 1.5× 110 5.0k
Gene G. Olinger United States 44 4.2k 1.2× 1.5k 0.7× 989 1.3× 469 0.7× 693 1.3× 91 5.8k
Darryl Falzarano Canada 30 4.1k 1.2× 690 0.3× 686 0.9× 259 0.4× 413 0.8× 69 5.2k
Jian‐Piao Cai China 40 4.3k 1.2× 1.1k 0.5× 762 1.0× 635 0.9× 602 1.2× 148 5.7k
W. Lim China 8 3.6k 1.1× 1.6k 0.8× 460 0.6× 366 0.5× 479 0.9× 10 5.0k
Bruno Coutard France 39 3.9k 1.1× 660 0.3× 1.8k 2.4× 1.1k 1.6× 654 1.3× 124 6.3k
Ronald Dijkman Switzerland 31 3.6k 1.0× 969 0.5× 600 0.8× 210 0.3× 577 1.1× 73 4.9k

Countries citing papers authored by Yousuke Furuta

Since Specialization
Citations

This map shows the geographic impact of Yousuke Furuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yousuke Furuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yousuke Furuta more than expected).

Fields of papers citing papers by Yousuke Furuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yousuke Furuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yousuke Furuta. The network helps show where Yousuke Furuta may publish in the future.

Co-authorship network of co-authors of Yousuke Furuta

This figure shows the co-authorship network connecting the top 25 collaborators of Yousuke Furuta. A scholar is included among the top collaborators of Yousuke Furuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yousuke Furuta. Yousuke Furuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nishi, Tatsuya, Katsuhiko Fukai, Kentaro Masujin, et al.. (2022). Administration of the antiviral agent T-1105 fully protects pigs from foot-and-mouth disease infection. Antiviral Research. 208. 105425–105425. 6 indexed citations
4.
Yamada, Hiroshi, Satoshi Taniguchi, Masayuki Shimojima, et al.. (2021). M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 13(6). 1061–1061. 5 indexed citations
5.
Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2020). Efficacy of favipiravir (T-705) against Crimean-Congo hemorrhagic fever virus infection in cynomolgus macaques. Antiviral Research. 181. 104858–104858. 23 indexed citations
6.
Julander, Justin G., et al.. (2020). Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus. Antiviral Research. 182. 104904–104904. 9 indexed citations
7.
Westover, Jonna B., Brady T. Hickerson, Arnaud J. Van Wettere, et al.. (2019). Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice. Pathogens. 8(4). 158–158. 13 indexed citations
8.
Tani, Hideki, Takashi Komeno, Aiko Fukuma, et al.. (2018). Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration. PLoS ONE. 13(10). e0206416–e0206416. 32 indexed citations
9.
Hawman, David W., Elaine Haddock, Kimberly Meade‐White, et al.. (2018). Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice. Antiviral Research. 157. 18–26. 60 indexed citations
10.
Dawes, Brian E., Birte Kalveram, Tetsuro Ikegami, et al.. (2018). Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Scientific Reports. 8(1). 7604–7604. 106 indexed citations
11.
Gowen, Brian B., Jonna B. Westover, Eric J. Sefing, et al.. (2017). Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy. Antiviral Research. 145. 131–135. 15 indexed citations
12.
Westover, Jonna B., Arnaud J. Van Wettere, Rong Li, et al.. (2017). Heartland virus infection in hamsters deficient in type I interferon signaling: Protracted disease course ameliorated by favipiravir. Virology. 511. 175–183. 26 indexed citations
13.
Yamada, Kentaro, Kyo Noguchi, Takashi Komeno, Yousuke Furuta, & Akira Nishizono. (2015). Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis. The Journal of Infectious Diseases. 213(8). 1253–1261. 72 indexed citations
14.
Scharton, Dionna, Kevin W. Bailey, Jonna B. Westover, et al.. (2014). Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Research. 104. 84–92. 83 indexed citations
15.
16.
Gowen, Brian B., Terry L. Juelich, Eric J. Sefing, et al.. (2013). Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever. PLoS neglected tropical diseases. 7(12). e2614–e2614. 64 indexed citations
17.
Kiso, Maki, Kyoko Shinya, Masayuki Shimojima, et al.. (2010). Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses. PLoS Pathogens. 6(8). e1001079–e1001079. 76 indexed citations
18.
Furuta, Yousuke, Kazumi Takahashi, Kimíyasu Shiraki, et al.. (2009). T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research. 82(3). 95–102. 378 indexed citations
19.
Gowen, Brian B., Min‐Hui Wong, Kie‐Hoon Jung, et al.. (2009). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Research. 86(2). 121–127. 55 indexed citations
20.
Matano, Tetsuro, Munehide Kano, Akiko Takeda, et al.. (2003). No significant enhancement of protection by Tat-expressing Sendai viral vector-booster in a macaque AIDS model. AIDS. 17(9). 1392–1394. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian B. Gowen Breakdown of academic impact, for papers by Friederike Feldmann Breakdown of academic impact, for papers by Dana Scott Breakdown of academic impact, for papers by Dale L. Barnard Breakdown of academic impact, for papers by Gene G. Olinger Breakdown of academic impact, for papers by Darryl Falzarano Breakdown of academic impact, for papers by Jian‐Piao Cai Breakdown of academic impact, for papers by W. Lim Breakdown of academic impact, for papers by Bruno Coutard Breakdown of academic impact, for papers by Ronald Dijkman
Rankless by CCL
2026